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Isolation, culture and characterization of human peritoneal mesothellal
cells. This study establishes a reproducible technique for the culture of
human peritoneal mesothelial cells. Direct explants, as well as enzy-
matically degraded specimens, of human omentum have been used as
the source of cells. Cells were grown on collagen and gelatin coated
matrices and were maintained in supplemented Ham's F-l2 medium
containing 10% (vol/vol) Fetal calf serum. Morphologically and ultra-
structurally, the cells formed a homogeneous population. They were
polygonal when confluent and devoid of contaminating fibroblasts,
endothelial cells and macrophages. Cultured mesothelial cells co-
expressed cytokeratin and vimentin and synthesized laminin, fibronec-
tin, mesosecrin, non-specific esterase and collagen Types I and III but
not Type IV. Ultrastructural features included numerous surface mi-
crovilli, cytoplasmic vesicles and an abundant endoplasmic reticulum.
The stimulation of mesothelial cells by the calcium ionophore A23 187
demonstrated that the two major products of arachidonic acid metabo-
lism were prostacyclin and prostaglandin E2. The peritoneal mesothelial
cell may be pivotal in the initiation of the inflammatory response during
peritonitis and its establishment in culture will provide the basis for an
in vitro model of peritoneal inflammation.
obtained from animal serosal tissue [8—il]. Growth of cells from
human ovarian carcinoma ascites fluid has been achieved using
specific growth factors [12], feeder layers [4] and specific
attachment substrates [6, 13]. A recent study has reported
mesothelial-like cells from a collagenase digest of human omen-
turn [10], but their characterization was incomplete.
Due to the conflicting evidence that exists with regard to the
availability and homogeneity of cell types obtained from serous
effusions [14] and in particular to avoid contamination by
malignant cells [7, 15], we have utilized direct explants of
human omentum as well as cells obtained by enzymatic disag-
gregation of this tissue. Both approaches have successfully and
reproducibly yielded homogeneous human mesothelial cell cul-
tures, the identity of which has been confirmed by immunohis-
tochemical and ultrastructural criteria.
Methods
Omentum explant culture
A monolayer of simple squamous epithelial cells of mesoder-
mal origin forms the limiting serosal membranes that line the
pleural, pericardial and peritoneal cavities. These mesothelial
cells act as a permeability barrier regulating the passage of fluid
and solutes between the systemic circulation and the body
cavities.
Peritoneal infection is the major complication of continuous
ambulatory peritoneal dialysis (CAPD), an increasingly com-
mon therapy for end-stage renal disease. In these circumstances
the interaction of invading bacteria with the mesothelial lining
may be pivotal in initiating the inflammatory response. The
establishment of human mesothelial cells in culture would
therefore provide the basis for an in vitro investigation of both
phagocyte-mesothelial cell and bacterial-mesothelial cell inter-
actions.
Although several detailed in vitro studies on cultured me-
sothelial cells have been reported, these have been limited to
the isolation of cells from human serous effusions [1—7] or those
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Specimens of human omentum were obtained from consent-
ing patients undergoing elective abdominal surgery. Blunt dis-
section removed excess fat and provided predominantly trans-
parent samples of tissue. The omentum was washed in several
changes of sterile phosphate buffered saline (PBS) (Oxoid,
Basingstoke, UK) pH 7.3, and finely divided into approximately
1 mm2 segments. These were washed in PBS three times to
remove any contaminating red blood cells. Explants were
seeded into collagen or gelatin coated 25 cm2 tissue culture
flasks (Falcon, Becton Dickinson, Oxford, UK), at a density of
approximately 1/cm2. Excess PBS was removed by aspiration
and replaced with a minimum volume (0.5 to 1 ml) of Ham's
F-12 medium (Flow Laboratories, Herts, UK), containing 20%
(vol/vol) fetal calf serum (FCS) (Flow Laboratories), supple-
mented with penicillin 100 U ml' and streptomycin 100 mg
ml1 (Gibco, Uxbridge, UK), transferrin 0.5 pg m11, insulin
0.5 j.g ml' (Sigma Chemicals, Poole, UK) and 2 mtvi glutamine
(Flow Laboratories). In some experiments the above medium
was further supplemented with one of the following growth
factors (final concentration): hydrocortisone (0.4 pg m1 1),
sodium selenite (5 ng ml'), cholera toxin (10 ng m1'),
epidermal growth factor (10 ng m11).
Fresh medium (a minimum volume of 0.5 to 1.0 ml, sufficient
to maintain viability) was added on alternate days until the
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explants adhered. At this stage, the volume of medium was
increased to 5 ml with Ham's F-l2, prepared as above, but
containing 15% (volJvol) FCS. Cells were cultured at 37°C in a
humidified atmosphere of 95% air:5% CO2.
Enzymatic disaggregation of omentum
Omental specimens were subjected to enzymatic disaggrega-
tion [modified from Verbrugh et al, 16]. Briefly, a piece of
washed omentum (approximately 6 cm2) was incubated with 15
ml of a solution containing 0.125% (wt/vol) trypsin, (Difco
Laboratories, West Moseley, UK), 0.01% (wt/vol) EDTA (Sig-
ma) and 0.1% (wt/vol) glucose (BDH Chemicals Ltd, Poole,
UK), for 20 minutes at 37°C with continuous rotation. After
incubation the suspension was centrifuged at 50 x g for five
minutes, at 4°C. The supernatant was discarded together with
the digested omentum which remained on the surface through-
out centrifugation. The cell pellet was washed once in culture
medium containing 10% (vol/vol) FCS, resuspended in the same
medium to a volume of 5 ml and seeded in 25 cm2 matrix coated
tissue culture flasks. Half the medium was exchanged 24 hours
after seeding and thereafter fully replaced once every three
days.
Passage of cell cultures
Confluent cells were washed with PBS and then incubated
with 2 ml of PBS containing 0.125% (wt/vol) trypsin, 0.01%
(wtlvol) EDTA and 0.1% (wtlvol) glucose for 4 to 5 seconds, at
room temperature. Most of the buffer was removed, leaving a
thin film of the liquid covering the cells, and cultures were then
incubated for 10 to 15 minutes at 37°C until the cells detached as
monitored by phase contrast microscopy. Free cells were
suspended and washed once in supplemented, antibiotic free
Ham's F-12 containing 10% (vollvol) FCS, centrifuged at 50 x
g for five minutes at 4°C, and seeded at a density of 1 to 2 X iO
cells/cm2 in collagen or gelatin coated flasks. Cell number was
estimated using an improved Neubauer chamber.
Preparation of matrix substrates
Twenty-five cm2 flasks were treated for 15 minutes at room
temperature with either 2.5 ml rat tail collagen (1 mg/mI)
prepared according to the method of Bornstein [171 or 2.5 ml of
0.1% (wt/vol) gelatin (denatured collagen; Sigma), both solu-
tions being made up in PBS, pH 7.3. Excess buffer was
removed, the surface allowed to air dry, and the flasks rinsed
three times with 2.5 ml PBS.
Transmission electron microscopy
All equipment and reagents used for transmission electron
microscopy (TEM), were obtained from EMScope (Ashford,
UK) unless otherwise stated. Primary and first passage con-
fluent mesothelial cells grown on Thermonox coverslips pre-
coated with collagen were fixed in 2.5% (voLtvol) glutaraldehyde
in 0.2 M cacodylate buffer, pH 7.4, at 4°C. After one hour fresh
cacodylate buffer was used to wash the cells. The coverslips
were then cut into 1 to 2 mm strips and post-fixed in 2%
(vol/vol) osmium tetroxide for two hours at room temperature.
Following a further wash in cacodylate buffer cells were sub-
jected to graded ethanol dehydration and propylene oxide
(BDH) immersion. Cells were then placed in propylene oxide:
araldite 1:1 (vol/vol) followed by fresh araldite at 35°C before
being left to polymerise at 60°C for 48 hours. Ultrathin (500 nm)
sections were cut perpendicular to the cell surface on a Cam-
bridge/Huxley Ultramicrotome Mark II, stained with uranyl
acetate and lead citrate and examined using a Phillips 300 TEM.
Scanning electron microscopy (SEM)
Fresh specimens of human omentum pinned flat, and con-
fluent cultures of human mesothelial cells grown on collagen
coated sterilized 24 mm2 glass coverslips (BDH), were fixed in
2.5% (vol/vol) glutaraldehyde in 0.2 M cacodylate buffer, pH
7.4. Whole tissue and confluent cultured cells were washed in
cacodylate buffer before being post-fixed in 1% (vol/vol) os-
mium tetroxide for approximately four hours. Both types of
preparation were then extensively washed with distilled water
and then subjected to graded ethanol dehydration; the latter
included 3 x 30 minute immersions in 100% ethanol with the
specimens being left in 100% ethanol until they were critically
point dried in a CPD 750 (EMScope Ltd.). At this stage the
dried specimens were mounted on 12.5 x 10 mm aluminium
stubs with an electroconductive adhesive before being gold
sputter-coated (cycle time 2.5 mm, deposition current 15 mA,
chamber vacuum 0.1 Torr; Sputter coater, EMScope) and
examined using a Jeol JSM-840A scanning electron microscope.
Immunohistochemistry (IHC)
Monoclonal antibodies to human cytokeratin (diluted 1:20
vollvol with PBS), vimentin (1:10 vol/vol PBS) and desmin,
(1:20 vol/vol PBS; Dako Ltd., Bucks, UK) were used. In
addition polyclonal antibodies to human fibronectin (1:10 vol/
vol PBS; Serotec, Oxford, UK), human factor VIII (gift of Dr.
D.C. West, Christie and Holt Radium Institute, Manchester,
UK), human laminin (gift of Dr. J. Couchman, Birmingham
Alabama, USA) and human collagens I, III, V (each diluted
1:40 vol/vol with PBS; Bionuclear Services Ltd., Reading, UK)
and type IV collagen (1:25 vol/vol PBS; Bionuclear Services,
London, UK) were used. The fluorescein conjugated second
antibodies were: rabbit anti-mouse, rabbit anti-goat, and goat
anti-rabbit from ICN Biomedicals Ltd., High Wycombe, UK
and swine anti-sheep from Serotec. Human peritoneal fibro-
blasts cultured separately were included as positive controls for
vimentin and fibronectin, and human kidney sections as posi-
tive controls for the remainder of the antibodies tested. Human
anti-mesosecrin (gift of J.G. Rheinwald, Boston, Massachu-
setts, USA) was also tested on mesothelial cells prepared as for
the other IHC tests except that cells were maintained in Ham's
F-l2 supplemented with only 0.1% (vol/vol) FCS for 24 hours
prior to fixation. The appropriate non-immune serum and PBS
in place of each primary antibody were used as controls for
non-specific fluorescence.
Primary and first passage monolayers, cultured on gelatin
coated petriperm (Heraeus, Brentwood, UK), were fixed in 1:1
(vollvol) cold acetone:methanol and incubated with 40 to 50 d
of the suitably diluted primary antibody for 45 minutes at room
temperature in a humidified chamber. The cells were washed
three times with PBS containing 0.8% (wt/vol) bovine serum
albumin (PBS-BSA), and then incubated with the appropriate
fluorescein conjugated second antibody for 45 minutes in the
dark in a humidified chamber. Cells were then extensively
washed with PBS-BSA, mounted and examined using a Leitz
fluorescence microscope.
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The presence of non-specific esterase and Fc receptors was
determined using the methods of Stuart, Habeshow and Dav-
idson [18] and Bianco and Pyrowski [19], respectively. For the
Fc receptor assay, sheep erythrocytes in Alsevers medium
(Tissue Culture Services Ltd., Slough, UK) were sensitized
using rabbit anti-sheep red blood cell stroma IgG (7s) (Sigma),
diluted 1:128 with PBS. Adherent human peritoneal macro-
phages prepared from eight-hour dwell CAPD effluent accord-
ing to the method of Alobaidi et al [20] were used as positive
controls for both the non-specific esterase and Fc receptor
assays.
Calcium ionophore stimulation
Primary or first passage mesothelial cells were seeded at a
density of 2 x io cells/cm2 in collagen coated 48-well tissue
culture plates (Costar, Northumbria Biologicals, UK). At con-
fluency, the cells were washed x 2 in Tyrodes-gelatin and 1 ml
of 10 isM calcium ionophore A23187 (Calbiochem-Behring,
Cambridge, UK) diluted in Tyrodes-gelatin was added per
well. Tyrodes-gelatin contained the following reagents, all from
BDH unless otherwise stated: 136.7 mM NaCI; 0.27 m KCI;
5.0 mM MgCI2 6H20; 0.4 mri NaH2PO4 2HO; 1.36 mM
CaCI2. 2H20; 5.0 mri D-glucose, 12.0 mt NaHCO3 and 0.1%
(wt/vol) Gelatin (Difco Labs); and was always prepared fresh on
the day of the experiment [21]. Incubations were performed in
5%C02:95% air in a humidified atmosphere at 37°C. At the end
of the incubation period, the supernatants were removed,
centrifuged, and stored at —20°C until required.
Quantitation of arachidonic acid (AA) metabolites
Prostaglandin E2 (PGE2), prostacyclin (PGI2) (measured as
6-keto-PGF1a), thromboxane (TXB2), leukotriene B4 (LTB4)
and leukotriene C4 (LTC4) were measured by specific radioim-
munoassays. Synthetically prepared prostaglandin standards
were obtained from Sigma. Leukotriene standards were syn-
thetically prepared (gift of Dr. B. Spur) and purified by reverse
phase high pressure liquid chromatography (RP-HPLC) prior to
use. Specific polyclonal antibodies (Bioclinical Services Ltd.
Cardiff, UK) were used for the prostaglandin estimations. The
antibodies to LTB4 and LTC4 were a gift of Dr. J. Rokach
(Merck Frosst, Montreal, Canada) [22]. Tritiated eicosanoids
were obtained from Amersham International (Aylesbury, UK),
and were: [3H] 6-keto-PGF1a, 157 Ci/mmol; and [3H] PGE2, 184
Cilmmol; [3H] TxB2, 180 Cilmmol; [3H] LTB4, 210 Cilmmol and
[3H] LTC4, 40.2 Ci/mmol.
The radioimmunoassays were performed in duplicate in total
volumes of 300 l Tris-Isogel buffer (0.1 M Tris-HCI, 0.14 M
NaCI, 0.1% wt/vol gelatin) [21], and contained 100 d samples of
supernatant or synthetic standard, 100 jsl of radiolabelled-
eicosanoid and 100 jsi of antibody in 3.5 ml polypropylene test
tubes (Sarstedt, Leicester, UK). The reaction mixtures were
incubates at 4°C overnight for all products other than LTB4
when the assay was incubated at 37°C. Bound and free ei-
cosanoid were separated by the addition of 250 js! of cold
dextran T70 (Pharmacia LKB, Milton Keynes, UK) coated
charcoal (Norit SX-1, BDH) both 1% wt/vol in Tris-Isogel
buffer and centrifuged immediately at 250 X g for 10 minutes at
4°C. Supernatants were decanted and mixed with 3.5 ml of
Optiphase MP scintillant (LKB Instruments, Poole, Dorset,
UK) and the radioactivity measured in a Rakbeta liquid scintil-
lation counter (LKB, Turku, Finland). Synthetic LTB4 and
LTC4 were detected over the linear portion of the radioligand
binding curve at concentrations ranging from 0.1 to 4 ng/ml
while PGE2, TxB2 and 6-keto-PGF1a were measured over the
linear part of the curve at concentrations ranging from 0.8 to 2.5
ng/ml.
Characterization of AA metabolites
Approximately 1 x io first passage mesothelial cells were
stimulated with 10 LM calcium ionophore for an appropriate
time, the supernatants mixed with an equal volume of methanol
at —20°C overnight and subsequently centrifuged at 11000 x g
for one minute at room temperature to remove the precipitated
proteins. The supernatant (2 ml) was injected directly onto a 5
C18 Nucleosil column (4.6 x 25.0 cm, Hichrom Ltd., Theale,
Reading, UK) protected by a 2 cm guard column of the same
material. Polar AA metabolites were eluted at a flow rate of 1
mi/mm in methanol:water:acetic acid 65:35:0.01, respectively,
at pH 5.6 for 30 minutes and monitored by UV absorption at 270
nm on a Gilson Holochrome dector (Anachem Ltd., Luton,
UK).
One milliliter fractions were collected and evaporated to
dryness under negative pressure in a Univap vaccum centrifuge
(Uniscience Ltd, Wandsworth, London, UK). The residue was
dissolved in 1 ml of Tris-Isogel buffer and examined for immu-
noreactive 6-keto-PGF1, PGE2, TXB2, LTB4 and LTC4. The
retention times for synthetic standards were: 3H 6-keto-PGF1,
seven minutes, PGE2 11 minutes, TXB2 nine minutes, LTB4 26
minutes.
Results
Cell culture
Explants. The initiation of a homogeneous mesothelial cell
population was dependent on the adherence of tissue explants
to the culture vessel surface. A minimum volume of 0.5 to 1 ml
of medium containing 20% (vol/vol) FCS was found to be
sufficient to maintain viability and at the same time facilitate
explant adherence. Cellular outgrowths from adhered explants
of human omentum were observed five days after initiation of
the culture. Growth was well established by 10 days and
confluency was usually obtained by 18 1 day (N = 11).
Morphologically the cells appeared bipolar, multipolar or even
elongated during the initial growth phase (Fig. 1) but immedi-
ately prior to, and at confluency, they adopted a polygonal
appearance characteristic of epithelial cells. Cell cultures ap-
peared homogeneous and growth occurred as a monolayer (Fig.
2). The ability to enhance the outgrowth of cells from the tissue
and to reduce the number of days required for monolayer
formation was investigated by supplementation of the medium
with the following compounds: hydrocortisone (0.4 g ml),
sodium selenite (5 ng ml), cholera toxin (10 ng ml) and
epidermal growth factor (10 ng ml'). Of these, only hydro-
cortisone had a beneficial effect, significantly reducing the
number of days to reach confluency from 18 1 day (N = 11)
to 13 2 days (N = 12; P < 0.001) days. It had, however, no
effect on the life span of cell cultures. Epidermal growth factor
also increased the rate of cell turnover but its routine addition to
the culture medium was precluded by its ability to induce a
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Fig. 1. Sub-confluent human mesothelial cells. The multipolar and
elongated morphology occurs during the initial growth phase in
culture. Magnification x 125.
Fig. 2. Confluent human mesothelial cell outgrowth from an explant
of omentum. The cells have adopted the polygonal appearance
characteristic at confluency. Magnification X 125.
Fig. 3. Fourth passage mesothelial cell culture demonstrating the
loss in unformity of the monolayer accompanied by the presence of
senescent cells. Magnification x 125.
reversible change in mesothelial cell morphology from a poly-
gonal to an elongated fibroblast like appearance.
Enzymatic disaggregation. Confluent mesothelial cells were
also obtained by limited treatment of the omentum with trypsin-
EDTA. This approach yielded on average three times the
number of confluent cultures per unit of tissue compared to the
explant method. Enzymatic digestion is clearly more efficient
than the explant method since it allows the direct plating of
disaggregated cells. The plating of 1 X io cells/cm2 resulted in
confluency in the presence of hydrocortisone in 8 1 day (N
12). The low concentration of trypsin used in this study (0.125%
wt/vol) together with the time of exposure of the omentum to
the enzyme resulted in an optimal yield of homogeneous
mesothelial cells. Increasing the concentration of trypsin and/or
the time of digestion beyond 25 to 30 minutes caused a
significant fibroblast contamination.
Propagation of cells. The confluent cells from both prepara-
tion methods were successfully passaged when seeded on either
collagen or gelatin coated matrices. Cells were subcultured at a
range of seeding densities from 3 x io to 5 x l0 cells/cm2.
Provided the seeding cell density was not less than 1 to 2 X l0
cells/cm2 the polygonal morphology observed at confluence was
maintained up to the sixth passage. Under these conditions the
cell density at confluency was 5.3 0.8 x 105/cm2 (N = 12).
The time to reach confluency for primary, secondary and
tertiary passaged cells did not vary and was approximately eight
days (N = 3, for each passage).
Cells seeded onto plastic did not proliferate beyond the third
passage whereas those seeded onto collagen or gelatin were
successfully cultured to the sixth passage. However, cells
cultured on collagen or gelatin beyond the third passage did
exhibit a gradual increase in cell size with the appearance of
large, non-proliferating or senescent cells (Fig. 3). Subse-
quently there was a reduction in proliferative capacity of fourth
and fifth passage cultures. Sixth passage cells lost viability
when subcultured, demonstrated by a failure to reattach to the
culture vessel surface. No cells with the morphological appear-
ance of fibroblasts or macrophages were observed in the
polygonal cell cultures.
Cells derived from both explants and enzyme digestion were
characterized by TEM, SEM and IHC. For these studies,
primary or first passage confluent cells were used.
Ultrastructure
TEM showed the presence of numerous surface microvilli,
abundant cytoplasmic vesicles and a well developed endoplas-
mic reticulum (Fig. 4). In addition large numbers of mitochon-
dna were present. Weibel-Palade bodies were not observed.
SEM verified the abundant microvilli on the surface of the
mesothelial cells of the omentum (Fig. 5A) and the retention of
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8.29 3.65 ng of PGE2 and 4.75 1.66 ng of 6-keto-PGF1, per
5 X lO cells over the same time period (Fig. 7). While the
increase in PGE2 synthesis was significant (P < 0.025, N =7)
the changes in 6-keto-PGF1, although doubled, failed to reach
significance (Wilcoxon matched-pairs rank test).
The pooled supernatants from 20 wells of confluent cells
containing 86.22 ng of immunoreactive 6-keto-PGF1 and 94.24
ng of immunoreactive PGE2 were resolved by RP-HPLC. The
immunoreactive peaks had retention times of seven minutes
and 10 minutes for 6-keto-PGF1 and PGE2, respectively. The
material eluting with the retention time of 6-keto-PGF1a con-
tained 64.1 ng of immunoreactive product giving a recovery of
74.3%. The material eluting with the retention time of PGE2
contained 76.76 ng of immunoreactive product giving a recov-
ery of8l.45%. TXB2, LTB4, and LTC4 were not detected in the
supernatant of control or ionophore stimulated cells.
Discussion
Fig. 4. Transmission electron micro graph of human mesothelial cells
stained with uranyl acetate and lead citrate. Numerous surface micro-
villi, abundant cytoplasmic vesicles, a well developed endoplasmic
reticulum and mitochondria are evident. Magnification x6,800.
these structures on the cultured cells (Fig. SB). Although the
density of cell-cell bridging and microvilli were reduced in the
cultured cells (Fig. 5B) these features were, however, retained
and demonstrate that the cultured cells maintain their mesothe-
hal phenotype. At no time were cells resembling fibroblasts or
macrophages observed.
Immunohistochemis try
IHC staining of confluent cells demonstrated that all cells
reacted positively for cytokeratin and vimentin (Fig. 6A,B) but
did not stain for desmin. Furthermore, cytokeratin negative
cells were not observed. The components of the mesothelial cell
extracellular matrix were shown to consist of laminin (Fig. 6C),
collagen Types I and III and fibronectin. Mesothelial cells
synthesized mesosecrin and non-specific esterase but they did
not synthesize factor VIII, collagen Type IV or Type V, nor did
they express surface Fc receptor activity.
Quantitation and characterization of AA metabolites
Confluent monolayers of cultured mesothehial cells generated
small quantities of immunoreactive PGE2 and 6-keto-PGF1 in
the absence of exogenous stimuli. Over a 60-minute incubation
period the cells produced 2.40 1.03 ng PGE2 and 2.15 0.62
ng 6 keto-PGF1a per 5 x io cells (mean SEM, N = 7). The
addition of the calcium lonophore A23187 resulted in an in-
crease in the generation of both cyclooxygenase metabolites to
The present study describes a reproducible technique for the
culture of human mesothehial cells. Cells of epithelial morphol-
ogy possessing structural features characteristic of mesothelial
cells were consistently obtained in defined culture conditions
from both explants and trypsin-EDTA treatment of human
omentum. Morphologically, histochemically and ultrastructur-
ally, the cultured cells formed a homogeneous population and
were devoid of contaminating fibroblasts (Table 1). Cells with
the characteristics of endothelial cells and macrophages were
also absent.
A feature of mesothelial cells in culture that has been
recognized for some time is their adoption of a heterogeneous
morphology [11, 23]. In the present study the cells appeared
multipolar or even elongated when isolated and became poly-
gonal only when confluent. Despite this, mesothelial cells
remained morphologically distinct from spindle-like connective
tissue fibroblasts. Fibroblast contamination of explant derived
cell cultures was minimized, first by dislodging adhered ex-
plants from which fibroblastic outgrowths were evident, and
second, by using passaging conditions that preferentially re-
moved cells of epithehial morphology. This was done by allow-
ing trypsinization to proceed only to the stage at which poiy-
gonal cells had detached while at the same time leaving the
fibroblast-like cells adhered. The use of relatively large (approx-
imately 6 cm2) samples of omentum for limited enzymatic
disaggregation (compared with 1 mm2 used for explants) mini-
mized contact between the enzyme and interstitial omental
fibroblasts, thereby restricting fibroblast contamination of the
cultures, The higher cell yield and, therefore, seeding density of
the enzymatically-derived primary mesothehial cell cultures
reduced the time required to attain confluency compared with
that required by the explant-derived cells.
The use of collagen or gelatin-coated substrates rather than
plastic alone has been reported to be important for maintaining
epithehial cell growth and differentiation in culture [24]. In our
studies mesothelial cells retained their morphology either on
gelatin or collagen coated surface for up to six successive
passages when seeded at a density of 1 to 2 x l0 cells/cm2,
whereas cells seeded onto plastic lost proliferative capacity
after three subcultures (N = 4). The importance of coated
substrates in human mesothehial cell growth and morphology is
not fully understood, although a recent study has shown that
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Fig. 5. A. Scanning electron micrograph of human omentum with abundant surface microvilli (bar = 10 jan). Magnification X 1700. 8. Scanning
electron micrograph of a cultured human mesothelial cell monolayer (Bar = 10 jm). Magnification x 1700.
Fig. 6. Immunofluorescent staining of fixed human mesothelial cells
with (A) monoclonal anti-cytokeratin, x250; (B) monoclonal anti-
vimentin, x250; (C) polyclonal anti-laminin, x400,
bovine corneal endothelial cell matrix is beneficial to hu- cells demonstrated the presence of numerous microvilli and
man mesothelial cells obtained from ovarian carcinoma ascite cytoplasmic vesicles. Both these features are characteristic of
fluid [6]. mesothelial cells in vivo [25] and have previously been de-
Ultrastructural examination of omentum-derived polygonal scribed in other ultrastructural studies [26—31]. The absence of
— --
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Fig. 7. Effect of the calcium ionophore A23187 (10 M, VA) on the
capacity of 5 x io human mesothelial cells to generate immunoreac-
tive PGI2 (measured as 6-keto-PGF,,) and PGE2 after one hour
incubation. Symbol () is Tyrodes. The mean SEM are given for each
dose from seven separate experiments.
Weibel-Palade bodies, organelles characteristically associated
with endothelial cells [32], further supports the identity of these
cells. In addition, a well developed endoplasmic reticulum and
abundant mitochondria were observed, indicative of a cell
involved in active protein synthesis and supporting the view
that the mesothelial cell is "far from a passive cell" [31].
The immunohistochemical demonstration of cytokeratin and
vimentin, two classes of intermediate filaments which are
constituents of epithelial and mesodermal cells, respectively
[33], confirms their embryological origin and agrees with obser-
vations on intact mesothelium [331. These findings are comple-
mented by the absence of the endothelial cell marker factor VIII
and the myogenic cell marker desmin.
Human mesothelial cells were positive for fibronectin which
confirms the finding in the mouse [34], and suggests that these
cells may play a role in the adhesion and migration of cells
across the peritoneal lining in vivo. Furthermore, the presence
of fibronectin, together with the basement membrane glycopro-
tein laminin, collagens I and III and the 46 kD glycoprotein,
mesosecrin (thought to be a constituent of the extracellular
matrix [351) suggests that human peritoneal mesothelial cells in
vitro, like their rat pleural counterparts, synthesize an orga-
nized extracellular matrix [36]. While the function of mesose-
cnn remains unknown [35], the other connective tissue compo-
nents may be important in conferring selective permeability to
the mesothelium in situ as well as contributing to the structural
integrity of the peritoneum itself. The identification of non-
specific esterase as a component of human mesothelial cells is
in agreement with several other authors [37—411, although there
is some controversy as to whether it is an authentic feature of
intact mesothelium [14]. Finally, the lack of Fe receptors on
human mesothelial cells demonstrated here concurs with the
finding by Geiling and co-workers [42] in rat mesothelium.
Human mesothelial cells in culture metabolize arachidonic
Table 1. Comparison of confluent mesothelial and omentum-derived
fibroblasts
Mesothelial cell Fibroblasts
Morphology polygonal elongated, stellate
Cytokeratin positive negative
Microvilli present absent
NSE positive negative
Mesosecrin strongly positive weakly positive
TxB2 not synthesized synthesized
acid to PGI2 and PGE2. In contrast, TXB2, LTB4 and LTC4
were not detected. This finding is similar to those from studies
of isolated rabbit peritoneal tissue and cultured rabbit mesothe-
hal cells [43,44]. PGI2, PGE2 and TXB2 are the three major
cyclooxygenase products that have been detected in human
peritoneal fluid either before or during episodes of peritonitis
[45]. Our results therefore suggest that the mesothelial cell may
be an important source of PGI2 and PGE2, but not TXB2 in the
peritoneal cavity. The capacity of mesothehial cells to synthe-
size these two major vasodilatory prostaglandins may facilitate
peritoneal hyperemia early in the inflammatory response. In
addition, both PG!2 and PGE2 may have a cytoprotective effect
[46] on the peritoneum during inflammation by acting to retain
the integrity of the mesothelial monolayer. Furthermore, PGE2
may exert a negative feedback effect on the release of Interleu-
kin 1 by peritoneal macrophages [47], thus regulating the
inflammatory response in the peritoneal cavity.
The present study will facilitate the in vitro examination of
the interaction of the mesothelium with phagocytic cells as well
as with bacteria. Thus, the establishment of human mesothelial
cells in culture provides the basis of a model for investigating
the role of the mesothelium in host defense mechanisms during
peritonitis. In addition the current study provides a useful
technique to study in vitro the physiology of human mesothe-
hum and its role in the transport of water and solutes.
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